Related Experiment Video
Updated: Jun 12, 2025

Author Spotlight: Collecting the Brain and Serum from the Same Mice Fetus to Study Brain Tumor Development
Published on: May 17, 2024
Risk of Neurodevelopmental Disorders in the Offspring of Young Female Cancer Survivors
Kyujin Choi1, Jihye Heo2,3, Soo-Young Oh4
1Department of Family Medicine, Seoul National University Hospital, 1, Gwanak-ro, Gwanak-gu, Seoul, Republic of Korea.
Insights
Children born to young female cancer survivors face a higher risk of neurodevelopmental disorders (NDDs). This increased risk, particularly for cerebral palsy and developmental delay, highlights the need for specialized care.
Area of Science:
- Reproductive Medicine
- Pediatrics
- Oncology
Background:
- Young female cancer survivors (under 40) represent a growing population.
- The impact of maternal cancer history on offspring neurodevelopmental outcomes requires further investigation.
- Understanding these risks is crucial for reproductive counseling and pediatric care.
Purpose of the Study:
- To investigate the association between maternal cancer history in women under 40 and the risk of neurodevelopmental disorders (NDDs) in their offspring.
- To identify specific NDDs associated with maternal cancer survivorship.
- To explore the influence of the timing of pregnancy relative to cancer diagnosis on NDD risk.
Main Methods:
- Retrospective cohort study utilizing nationwide data from the Korean National Health Insurance Service (2005-2019).
- Inclusion of 19,474 children born to female cancer survivors under 40.
- Propensity-score matching (1:3) with 58,422 controls; NDDs identified via ICD-10 codes; Hazard Ratios (HRs) calculated.
Main Results:
- Children of young female cancer survivors exhibited an increased overall risk of NDDs (HR=1.10).
- Specific elevated risks observed for cerebral palsy (HR=1.38), developmental delay (HR=1.16), and epileptic/febrile seizures (HR=1.06).
- The risk was highest for offspring diagnosed with cancer during pregnancy (HR=1.26); no significant difference noted for births >5 years post-diagnosis (HR=1.07).
Conclusions:
- Offspring born to young female cancer survivors have a statistically significant increased risk of neurodevelopmental disorders.
- Maternal cancer diagnosis during pregnancy poses a particularly high risk for NDDs in offspring.
- Healthcare providers should counsel young female cancer survivors on potential NDD risks for their children and recommend appropriate surveillance.
Abstract:
This study aimed to examine the risk of neurodevelopmental disorders (NDDs) in cJihye Heohildren born to female cancer survivors under 40 years old. Using nationwide retrospective data from the Korean National Health Insurance Service between January 1, 2005, and December 31, 2019, we included 19,474 children born to female cancer survivors under 40 years old. Propensity-score matching (1:3) with 58,422 controls born to women without cancer was conducted. NDDs were identified using ICD-10 codes. Hazard ratios (HRs) were calculated to assess the relative risk. Children born to cancer survivors had a higher overall risk of NDDs (HR = 1.10; 95% CI 1.05-1.15), with specific elevated risks for cerebral palsy (HR = 1.38; 95% CI 1.05-1.81), developmental delay (HR = 1.16; 95% CI 1.06-1.26), and epileptic and febrile seizures (HR = 1.06; 95% CI 1.01-1.12). The risk was particularly elevated in children whose mothers were diagnosed with cancer during pregnancy (HR = 1.26; 95% CI 1.08-1.47). However, for births occurring more than 5 years after the cancer diagnosis, the difference in NDDs risk was not statistically significant (HR = 1.07; 95% CI 0.98-1.16). The offspring of young female cancer survivors had an increased risk of NDDs compared with the control group. When young female cancer survivors desire pregnancy, healthcare providers should offer appropriate counseling and surveillance for potential adverse NDDs in their offspring.
Related Concept Videos
Psychoneuroimmunology: Diabetes and Cancer
Disorders of the Female Reproductive System
Cancer Prevention
Some...
Teratogenicity
Meiosis vs. Mitosis
Before the start of mitosis and meiosis I, the cell synthesizes DNA, resulting in two homologous copies of each chromosome. DNA synthesis is...
Oogenesis

